advertisement
Berdahl JP 20
Showing records 1 to 20 | Display all abstracts from Berdahl JP116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Ophthalmology 2024; 131: 1021-1032
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Vander Zee BL; Wilson C
Journal of Current Glaucoma Practice 2024; 18: 63-67
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Sarkisian SR
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE; Lee AM
Ophthalmology 2024; 131: 1021-1032
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Berdahl JP
Journal of Current Glaucoma Practice 2024; 18: 63-67
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Ang RE; Doan LV
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Berdahl JP
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV
Drugs 2024; 84: 83-97
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Terveen D
Journal of Current Glaucoma Practice 2024; 18: 63-67
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Heersink SB
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC
Drugs 2024; 84: 83-97
117280 Superonasal vs Inferonasal Subconjunctival Gel Stent Placement in Patients with Glaucoma
Ferguson TJ
Journal of Current Glaucoma Practice 2024; 18: 63-67
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Burden JH
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Usner DW
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Katz LJ
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Doan LV; Stephens KG
Ophthalmology 2024; 131: 1021-1032
116785 Efficacy and Safety of the Travoprost Intraocular Implant in Reducing Topical IOP-Lowering Medication Burden in Patients with Open-Angle Glaucoma or Ocular Hypertension
Navratil T;
Drugs 2024; 84: 83-97
117190 Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension
Kothe AC; Usner DW; Katz LJ; Navratil T;
Ophthalmology 2024; 131: 1021-1032
